Bayer Shares Plunge After Monsanto Loses Roundup Cancer Trial

The transcript discusses the financial and legal implications for Bayer after Monsanto was ordered to pay $289 million in damages over claims that Roundup causes cancer. Investors are worried about the potential for further lawsuits and financial liabilities. Bayer has not responded, but Monsanto maintains that studies show Roundup's main ingredient does not cause cancer.

What was the financial impact on Monsanto after the legal ruling?

• $500 million in damages

• $100 million in damages

• $1 billion in damages

• $289 million in damages

Why are investors concerned about the Monsanto case?

• Potential increase in product prices

• Changes in company leadership

• Uncertainty and potential legal liabilities

• Decrease in product demand

What could be a consequence of the Monsanto verdict, even if it doesn't stand?

• Increased production costs

• Need to pay settlement costs for other suits

• Expansion into new markets

• Reduction in workforce

What is Monsanto's stance on the cancer claims related to Roundup?

• They have not commented on the claims

• They are undecided on the claims

• They believe the claims are unfounded

• They acknowledge the claims

According to Monsanto, what do their studies show about Roundup's main ingredient?

• It causes cancer

• It does not cause cancer

• It has no effect on health

• It is beneficial to health